Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million 2023-08-16 19:00
MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems at Medlab Asia & Asia Health 2023 2023-08-16 11:00
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency 2023-08-16 01:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors 2023-08-15 20:00
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System 2023-08-15 16:52
Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM 2023-08-15 09:00
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint 2023-08-14 12:50
International Youth Day 2023: Angel Yeast Paves Path for Young Employees, Supporting Sustainable Talent Development 2023-08-12 20:00
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach 2023-08-11 21:14
Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials 2023-08-11 21:00
Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer 2023-08-11 17:00
WuXi XDC and Boostimmune Sign MOU for Integrated Services 2023-08-11 08:30
WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services 2023-08-11 08:30
Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China 2023-08-11 08:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 07:18
1 87 88 89 90 91 452